Clinical Trial of Auceliciclib in patients with advanced solid tumours

Phase 1, Multi-Site, Australia, (Protocol: AU08-001-01)

Lead Site: SOCRU, Bedford Park, SA, Australia

Medical Monitor: Dr Paul Wabnitz, MD, PhD, MBA, FRACP (paul.wabnitz@clinPHARMA.com.au)

Sponsor: Aucentra Therapeutics

Status: Actively recruiting Phase 1a

Active Sites:

Southern Oncology Clinical Research Unit (SOCRU), Bedford Park, South Australia

Sydney South West Private Hospital, Liverpool, New South Wales 2170

Austin Health, Heidelberg, Victoria, 3084

A Phase 1a/b, open-label, dose-exploration, combination/expansion study to evaluate the safety, tolerability and pharmacokinetics of Auceliciclib in advanced solid tumours and in combination with Temozolomide in recurrent or newly diagnosed Glioblastoma multiforme (GBM).

For more information, this Trial is registered on the Australian New Zealand Clinical Trials Registry (ANZCTR). Additional detailed information can be found by the following links:

https://www.anzctr.org.au/ACTRN12621000479808.aspx

https://www.australiancancertrials.gov.au/search-clinical-trials/search-results/clinical-trials-details.aspx?TrialID=381399&ds=1